Weston Nichols, 10% Owner at TScan Therapeutics, Inc. (TCRX), bought 947 shares at $4.34 ($4K) on 2024-11-15, disclosed to the SEC on 2024-11-19.
Open-market purchase of $4k TCRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| TCRX | BUY | 2024-12-16 | $386K | — | Filing → |